Lomitapide
Juxtapid, Lojuxta (lomitapide) is a small molecule pharmaceutical. Lomitapide was first approved as Juxtapid on 2012-12-21. It is used to treat hypercholesterolemia in the USA. It has been approved in Europe to treat hypercholesterolemia. Juxtapid's patents are valid until 2027-08-19 (FDA).
Trade Name | Lojuxta |
---|---|
Common Name | Lomitapide |
Indication | hypercholesterolemia |
Drug Class | Microsomal triglyceride transfer protein (MTP) inhibitors |